EQS-News

    197 Aufrufe 197 0 Kommentare 0 Kommentare

    Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU)

    Für Sie zusammengefasst
    • Evotec opens J.POD facility in Toulouse, France.
    • New tech enables cost-effective biologics manufacturing.
    • Facility enhances Europe's capacity for biotherapeutics.
    EQS-News - Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU)

    EQS-News: Evotec SE / Key word(s): Miscellaneous
    Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU)

    20.09.2024 / 15:29 CET/CEST
    The issuer is solely responsible for the content of this announcement.


     
    • J.POD Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region
    • Just – Evotec Biologics’ J.POD technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and commercial supply solutions
     

    Hamburg, Germany, and Toulouse, France, 20 September 2024:
    Just – Evotec Biologics, the biologics segment of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO), today celebrated the Grand Opening of its J.POD biologics development and manufacturing facility located on Evotec’s Campus Curie in Toulouse, France. The J.POD facility in Toulouse, the second of its kind and the first in Europe, utilizes Just – Evotec Biologics’ adaptable J.POD technology to provide essential clinical and commercial biologics manufacturing capacity.

    During a ceremony on Campus Curie, Pierre-André Durand, Prefect of Haute-Garonne and Occitanie, Jean-Luc Moudenc, President of Toulouse Métropole and Mayor of Toulouse as well as Jalil Benabdillah, Vice-President, Economy, Employment, Innovation and Reindustrialisation of the Occitanie region, joined the Management of Evotec and Just – Evotec Biologics, to inaugurate the new facility.

    Dr Christian Wojczewski, Chief Executive Officer of Evotec, commented: “J.POD is a bioprocessing facility by Just – Evotec Biologics that uses advanced technology to fulfill its mission of making biotherapeutics more accessible worldwide. The opening of J.POD Toulouse, France (EU), our first J.POD on European ground, represents a proud moment and a significant milestone for our Company. We are very thankful for the support from the French government, the Occitanie Region, Bpifrance, the Haute-Garonne prefecture, and Toulouse Métropole for helping us achieve this milestone at our Campus Curie in Toulouse. We also want to give special credit to our dedicated team, whose hard work and commitment made this possible.”

    Seite 1 von 5



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU) EQS-News: Evotec SE / Key word(s): Miscellaneous Just – Evotec Biologics opens cutting-edge biologics facility - J.POD Toulouse, France (EU) 20.09.2024 / 15:29 CET/CEST The issuer is solely responsible for the content of this announcement.   …